Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for ...

Five-year grant of $7 million annually to the academic researchers is aimed at accelerating the development of new therapeutics to combat ...